默克公司的 Keytruda：救命药物，全球分歧
德国之声和 ICIJ 的一项跨境调查揭示了定价和专利如何帮助将一种救命药物变成世界上最畅销的药物之一，同时让许多患者难以获得它。
schedule
05:06
visibility
85 浏览
来源: DW News
A cross-border investigation by DW and ICIJ reveals how pricing and patents helped turn a life-saving medicine into one of the world's best selling drugs while leaving many patients struggling to access it.